Vegzelma Unión Europea - danés - EMA (European Medicines Agency)

vegzelma

celltrion healthcare hungary kft. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastiske midler - vegzelma in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. vegzelma in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. for yderligere information om human epidermal vækstfaktor receptor 2 (her2) status henvises til afsnit 5. vegzelma in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with vegzelma in combination with capecitabine. for yderligere oplysninger om her2-status henvises til afsnit 5. vegzelma, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer (nsclc) other than predominantly squamous cell histology. vegzelma, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent nsclc with epidermal growth factor receptor (egfr) activating mutations (see section 5. vegzelma, in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. vegzelma, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. vegzelma, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (vegf) inhibitors or vegf receptor–targeted agents. vegzelma in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents (see section 5. vegzelma, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Vibrance Gold Flydende bejdse Dinamarca - danés - SEGES Landbrug & Fødevarer

vibrance gold flydende bejdse

syngenta nordics a/s - difenoconazol, fludioxonil, sedaxan - flydende bejdse - 25 g/l difenoconazol; 25 g/l fludioxonil; 50 g/l sedaxane

Tekcis radionuklidgenerator Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

tekcis radionuklidgenerator

cis bio international oris ind. - natriummolybdat (99m-mo) - radionuklidgenerator

Cruiser OSR Flydende bejdse Dinamarca - danés - SEGES Landbrug & Fødevarer

cruiser osr flydende bejdse

syngenta nordics a/s - fludioxonil, thiamethoxam, metalaxyl-m - flydende bejdse - 8 g/l fludioxonil ; 280 g/l thiamethoxam ; 33,3 g/l metalaxyl-m

Vibrance Duo Flydende bejdse Dinamarca - danés - SEGES Landbrug & Fødevarer

vibrance duo flydende bejdse

syngenta nordics a/s - fludioxonil, sedaxan - flydende bejdse - 25 g/l fludioxonil; 25 g/l sedaxane

Vibrance Star Flydende middel Dinamarca - danés - SEGES Landbrug & Fødevarer

vibrance star flydende middel

syngenta nordics a/s - fludioxonil, triticonazol, sedaxan - flydende middel - 25 g/l fludioxonil; 20 g/l triticonazol; 25 g/l sedaxane

Vepacel Unión Europea - danés - EMA (European Medicines Agency)

vepacel

ology bioservices ireland ltd - influenzavirus (hel virion, inaktiveret), der indeholder antigen af: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenzavacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. denne angivelse er baseret på immunogenicitet data fra forsøgspersoner i alderen fra 6 måneder og frem efter administration af to doser af vaccinen tilberedes med h5n1 subtype stammer. vepacel bør anvendes i overensstemmelse med officielle retningslinjer.

Enstilar 50 mikrog/g+0,5 mg/g kutanskum Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

enstilar 50 mikrog/g+0,5 mg/g kutanskum

abacus medicine a/s - betamethasondinatriumphosphat, calcipotriol - kutanskum - 50 mikrog/g+0,5 mg/g

Enstilar 50 mikrog/g+0,5 mg/g kutanskum Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

enstilar 50 mikrog/g+0,5 mg/g kutanskum

leo pharma a/s - betamethasondinatriumphosphat, calcipotriol - kutanskum - 50 mikrog/g+0,5 mg/g

Enstilar 50 mikrog/g+0,5 mg/g kutanskum Dinamarca - danés - Lægemiddelstyrelsen (Danish Medicines Agency)

enstilar 50 mikrog/g+0,5 mg/g kutanskum

2care4 aps - betamethasondinatriumphosphat, calcipotriol - kutanskum - 50 mikrog/g+0,5 mg/g